Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (72)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thieben, M. J.
Right arrow Articles by Frackowiak, R. S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thieben, M. J.
Right arrow Articles by Frackowiak, R. S. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 125, No. 8, 1815-1828, August 2002
© 2002 Guarantors of Brain

The distribution of structural neuropathology in pre-clinical Huntington’s disease

M. J. Thieben1, A. J. Duggins4, C. D. Good4, L. Gomes2, N. Mahant1, F. Richards3, E. McCusker1 and R. S. J. Frackowiak4

Departments of 1 Neurology and 2 Radiology, Westmead Hospital, 3 Department of Clinical Genetics, The Children’s Hospital at Westmead, NSW, Australia, 4 Wellcome Department of Imaging Neuroscience, Institute of Neurology, London, UK

Correspondence to: A. J. Duggins, Clinical Superintendent, Division of Medicine, Westmead Hospital, Hawkesbury Road, Westmead, NSW 2145, Australia E-mail: andrewd{at}westgate.wh.usyd.edu.au

Putative neuroprotective agents in Huntington’s disease may have particular application before brain pathology becomes manifest clinically. If these agents were to be tested in clinical trials, a reliable marker of the burden and rate of progression of pathological change in the pre-clinical group would be needed. The present study investigates whether the Huntington’s disease genotype is associated with regional differences in brain structure, particularly differences that could not be predicted from clinical or neuropsychological assessment. A secondary aim is to seek indirect evidence of pathological progression in the form of changes in local tissue volume with age, specific to the Huntington’s disease genotype. Formal motor examination, neuropsychological assessment, and T1-weighted cerebral MRI were performed in 34 subjects who had undergone predictive genetic testing for Huntington’s disease. Clinical and cognitive testing were performed blinded to gene status. A linear discriminant analysis revealed the combination of test scores (the ‘optimal clinical score’) which best differentiated 18 subjects carrying the Huntington’s disease gene mutation (the ‘gene-positive’ group). Voxel-based morphometry (VBM) was used to identify regions of significant main effect of Huntington’s disease gene status on grey and white matter volume and regions of significant interaction of gene status with age. In the gene-positive group, there was significant reduction in grey matter volume in the left striatum, bilateral insula, dorsal midbrain and bilateral intra-parietal sulcus relative to ‘gene-negative’ controls. There was a significant reduction of periventricular white matter volume with age bilaterally in the gene-positive relative to the gene-negative group. Changes remained significant when controlled for differences in optimal clinical score between subjects. This study provides evidence of distributed grey matter pathology and progressive white matter atrophy with age before clinical onset of Huntington’s disease. This suggests that VBM may be useful in monitoring cross-sectional and longitudinal changes in brain structure in pre-clinical Huntington’s disease and for determining the efficacy of neuroprotective agents.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
S. Kloppel, B. Draganski, H. R. Siebner, S. J. Tabrizi, C. Weiller, and R. S. J. Frackowiak
Functional compensation of motor function in pre-symptomatic Huntington's disease
Brain, June 1, 2009; 132(6): 1624 - 1632.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. Aviezer, S. Bentin, R. R. Hassin, W. S. Meschino, J. Kennedy, S. Grewal, S. Esmail, S. Cohen, and M. Moscovitch
Not on the face alone: perception of contextualized face expressions in Huntington's disease
Brain, June 1, 2009; 132(6): 1633 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Muhlau, A.M. Wohlschlager, C. Gaser, M. Valet, A. Weindl, S. Nunnemann, A. Peinemann, T. Etgen, and R. Ilg
Voxel-Based Morphometry in Individual Patients: A Pilot Study in Early Huntington Disease
AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 539 - 543.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Kloppel, C. Chu, G. C. Tan, B. Draganski, H. Johnson, J. S. Paulsen, W. Kienzle, S. J. Tabrizi, J. Ashburner, R.S.J. Frackowiak, et al.
Automatic detection of preclinical neurodegeneration: Presymptomatic Huntington disease
Neurology, February 3, 2009; 72(5): 426 - 431.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. De Diego-Balaguer, M. Couette, G. Dolbeau, A. Durr, K. Youssov, and A.-C. Bachoud-Levi
Striatal degeneration impairs language learning: evidence from Huntington's disease
Brain, November 1, 2008; 131(11): 2870 - 2881.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger, et al.
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 874 - 880.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Ilg, A. M. Wohlschlager, C. Gaser, Y. Liebau, R. Dauner, A. Woller, C. Zimmer, J. Zihl, and M. Muhlau
Gray Matter Increase Induced by Practice Correlates with Task-Specific Activation: A Combined Functional and Morphometric Magnetic Resonance Imaging Study
J. Neurosci., April 16, 2008; 28(16): 4210 - 4215.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Teichmann, V. Gaura, J.-F. Demonet, F. Supiot, M. Delliaux, C. Verny, P. Renou, P. Remy, and A.-C. Bachoud-Levi
Language processing within the striatum: evidence from a PET correlation study in Huntington's disease
Brain, April 1, 2008; 131(4): 1046 - 1056.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. D. Rosas, D. H. Salat, S. Y. Lee, A. K. Zaleta, V. Pappu, B. Fischl, D. Greve, N. Hevelone, and S. M. Hersch
Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity
Brain, April 1, 2008; 131(4): 1057 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. Beste, C. Saft, J. Andrich, R. Gold, and M. Falkenstein
Stimulus-Response Compatibility in Huntington's Disease: A Cognitive-Neurophysiological Analysis
J Neurophysiol, March 1, 2008; 99(3): 1213 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H H Ruocco, L Bonilha, L M Li, I Lopes-Cendes, and F Cendes
Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 130 - 135.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Kloppel, B. Draganski, C. V. Golding, C. Chu, Z. Nagy, P. A. Cook, S. L. Hicks, C. Kennard, D. C. Alexander, G. J. M. Parker, et al.
White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease
Brain, January 1, 2008; 131(1): 196 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Garraux, P. Peigneux, R. E. Carson, and M. Hallett
Task-Related Interaction between Basal Ganglia and Cortical Dopamine Release
J. Neurosci., December 26, 2007; 27(52): 14434 - 14441.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. D. Nave, S. Foresti, A. Pratesi, A. Ginestroni, M. Inzitari, E. Salvadori, M. Giannelli, S. Diciotti, D. Inzitari, and M. Mascalchi
Whole-Brain Histogram and Voxel-Based Analyses of Diffusion Tensor Imaging in Patients with Leukoaraiosis: Correlation with Motor and Cognitive Impairment
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1313 - 1319.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. A. Johnson, J. C. Stout, A. C. Solomon, D. R. Langbehn, E. H. Aylward, C. B. Cruce, C. A. Ross, M. Nance, E. Kayson, E. Julian-Baros, et al.
Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease
Brain, July 1, 2007; 130(7): 1732 - 1744.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Daniels, M. Peller, S. Wolff, K. Alfke, K. Witt, C. Gaser, O. Jansen, H. R. Siebner, and G. Deuschl
Voxel-based morphometry shows no decreases in cerebellar gray matter volume in essential tremor
Neurology, October 24, 2006; 67(8): 1452 - 1456.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. Lasek, R. Lencer, C. Gaser, J. Hagenah, U. Walter, A. Wolters, N. Kock, S. Steinlechner, M. Nagel, C. Zuhlke, et al.
Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17)
Brain, September 1, 2006; 129(9): 2341 - 2352.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. Finke, P. Bublak, M. Dose, H. J. Muller, and W. X. Schneider
Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease
Brain, May 1, 2006; 129(5): 1137 - 1151.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Suzuki, T. Hoshino, K. Shigemasu, and M. Kawamura
Disgust-specific impairment of facial expression recognition in Parkinson's disease
Brain, March 1, 2006; 129(3): 707 - 717.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Ciarmiello, M. Cannella, S. Lastoria, M. Simonelli, L. Frati, D. C. Rubinsztein, and F. Squitieri
Brain White-Matter Volume Loss and Glucose Hypometabolism Precede the Clinical Symptoms of Huntington's Disease
J. Nucl. Med., February 1, 2006; 47(2): 215 - 222.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
J. Kassubek, F. D. Juengling, D. Ecker, and G. B. Landwehrmeyer
Thalamic Atrophy in Huntington's Disease Co-varies with Cognitive Performance: A Morphometric MRI Analysis
Cereb Cortex, June 1, 2005; 15(6): 846 - 853.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C M Kipps, A J Duggins, N Mahant, L Gomes, J Ashburner, and E A McCusker
Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study
J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 650 - 655.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. J. Calder, J. Keane, A. D. Lawrence, and F. Manes
Impaired recognition of anger following damage to the ventral striatum
Brain, September 1, 2004; 127(9): 1958 - 1969.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Mascalchi, F. Lolli, R. D. Nave, C. Tessa, R. Petralli, C. Gavazzi, L. S. Politi, M. Macucci, M. Filippi, and S. Piacentini
Huntington Disease: Volumetric, Diffusion-weighted, and Magnetization Transfer MR Imaging of Brain
Radiology, September 1, 2004; 232(3): 867 - 873.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hennenlotter, U. Schroeder, P. Erhard, B. Haslinger, R. Stahl, A. Weindl, H. G. von Einsiedel, K. W. Lange, and A. O. Ceballos-Baumann
Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease
Brain, June 1, 2004; 127(6): 1446 - 1453.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Kassubek, F D Juengling, T Kioschies, K Henkel, J Karitzky, B Kramer, D Ecker, J Andrich, C Saft, P Kraus, et al.
Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study
J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 213 - 220.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Mahant, E.A. McCusker, K. Byth, and S. Graham
Huntington's disease: Clinical correlates of disability and progression
Neurology, October 28, 2003; 61(8): 1085 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
K. Specht, M. Minnerop, M. Abele, J. Reul, U. Wullner, and T. Klockgether
In Vivo Voxel-Based Morphometry in Multiple System Atrophy of the Cerebellar Type
Arch Neurol, October 1, 2003; 60(10): 1431 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. S. Bagary, M. R. Symms, G. J. Barker, S. H. Mutsatsa, E. M. Joyce, and M. A. Ron
Gray and White Matter Brain Abnormalities in First-Episode Schizophrenia Inferred From Magnetization Transfer Imaging
Arch Gen Psychiatry, August 1, 2003; 60(8): 779 - 788.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G B Frisoni, C Testa, A Zorzan, F Sabattoli, A Beltramello, H Soininen, and M P Laakso
Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry
J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(6): 657 - 664.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.